Contact Financial News and Press Releases
Gives Update on Tandelle-Pacer Acquisition November 6, 2018 – Nanaimo, British Columbia. ATLAS ENGINEERED PRODUCTS LTD. (“Atlas” or the “Company”) (TSX-V: AEP, OTC Markets: APEUF) is pleased to report that it has closed the first tranche of its non-brokered private placement offering (the “Offering”) previously announced on August 14, 2018 and October 18, 2018.
VICTORIA, Oct. 29, 2018 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) is excited to expand its immunization services through our recent growth in Europe. Our advanced genetic immunization strategies are applicable in multiple species, including transgenics, and across all discovery platforms. We have developed our genetic immunization protocol with our proprietary vectors to
Pioneering’s SmartBurner Now Available at Best Buy in the U.S. to Consumers Both at Retail and On-line
Best Buy is first US Retailer to make SmartBurner available in-store SmartBurner included in Best Buy’s new “Seniors Care Solutions” program (Mississauga, ON October 29, 2018) – Pioneering Technology Corp. (TSXV: PTE; OTC: PTEFF), (“Pioneering” or the “Company”), North America’s leader in cooking fire prevention technologies and products is pleased to announce
ATLAS ENGINEERED PRODUCTS REPORTS YEAR OVER YEAR Q1 REVENUE GROWTH OF 85.6% TO A RECORD $5.08 MILLION AND ANNOUNCES APPOINTMENT OF DIRK MARITZ AS CHIEF EXECUTIVE OFFICER
Atlas Also Announces Update to Terms of Private Placement Offering and Issuance of Shares for Interest on Exchangeable Notes October 18, 2018 – Nanaimo, British Columbia. ATLAS ENGINEERED PRODUCTS LTD. (“Atlas” or the “Company”) (TSX-V: AEP) yesterday reported its financial results for the quarter ended August 31, 2018. The financial statements and related management’s discussion
Wrap-up of 2018 Annual General Meeting of Shareholders Vancouver, British Columbia, October 16, 2018 – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to report the results of the 2018 Annual General Meeting of Shareholders as held October 15, 2018. All matters presented and recommended by
Universal mCloud Commences the Process to List on the NASDAQ and Implements New Board and Management Assignments to Align With 2019 Growth Strategies
Darren Anderson appointed Chief Financial Officer Michael A. Sicuro to lead NASDAQ Listing Special Committee Formed and Audit Committee Augmented to Align Governance VANCOUVER, Oct. 16, 2018 /CNW/ – Universal mCloud Corp. (TSX-V: MCLD) (“mCloud” or the “Company”), a leading provider of AI, Analytics and IoT-cloud connected, asset-care technology solutions announced today that it has begun the process
mCloud Oversubscribes its Non-Brokered Private Placement by more than 225% /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Attracts national and international investment Moves to close the recently announced Ascent AeroSystems acquisition Receives overwhelming response from inaugural mCloud Connect conference
Victoria, British Columbia, Canada, October 15th, 2018 – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that ModiQuest® Research, an ImmunoPrecise Company, is now an OmniAb approved CRO, which enables ImmunoPrecise to offer OmniAb services in both the US and Europe. This approval allows ImmunoPrecise to further expand its
VICTORIA, Oct. 9, 2018 – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that it has signed an agreement and initiated an antibody development program with an undisclosed, top 15, global pharmaceutical company, to discover novel antibodies using ImmunoPrecise’s proprietary hybridoma technology. ImmunoPrecise’s hybridoma platform allows for
VANCOUVER, British Columbia, Oct. 04, 2018 – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Company has made a strategic investment in Pasha Brands, via their current equity capital financing. Pasha is a west coast company firmly established in B.C’s craft cannabis industry
CALGARY, Oct. 3, 2018 /CNW/ – Renoworks Software Inc. (TSXV: RW) (“Renoworks”), the leading visualization platform for the home remodeling and construction industry, and CertainTeed (“CertainTeed”), the innovative provider of building products, are pleased to unveil a newly-enhanced ColorView® Visualization Tool. The already-popular ColorView takes advantage of Renoworks’ latest web visualizer updates, including improved visualization tools, enhanced user navigation, and the
VANCOUVER, Oct. 3, 2018 /CNW/ – LITE ACCESS TECHNOLOGIES INC. (the “Company“) (TSX VENTURE: LTE)(PINK: LTCCF), a world leader in the use of innovative and proven micro/narrow trenching technologies, alternate methods of deployment and specialist products which transform the cost of fibre optic network deployment for telecommunications operators, today is pleased to announce selected preliminary unaudited financial results for the
VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) — ATLAS ENGINEERED PRODUCTS LTD. (“Atlas” or the “Company”) (TSX-V: AEP), a leading supplier of trusses, engineered wood products and building components, is pleased to announce that it has completed the acquisition of all the issued and outstanding shares of Coastal Windows Ltd. (“Coastal Windows”) of Nanaimo, British Columbia.
Victoria, British Columbia, Canada, October 2nd, 2018 – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) announced the addition of in-house and custom phage libraries to their growing service offerings through their recent expansion in Europe. Through construction and screening of scFv and VHH phage display libraries, ImmunoPrecise is able
October 1st, 2018 – Victoria, British Columbia. IMMUNOPRECISE ANTIBODIES LTD. (“ImmunoPrecise”) (TSX Venture: IPA, Pink Sheets: IPATF) today reports its financial results for Q1 ended July 31, 2018. The financial statements and related management’s discussion and analysis (“MD&A”) can be viewed on SEDAR at www.sedar.com. Financial Highlights: Revenue. During the three months ended July
Victoria, British Columbia, Canada, September 28, 2018 – IMMUNOPRECISE ANTIBODIES LTD. (“ImmunoPrecise” or “IPA”) (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has closed its previously announced non-brokered private placement financing by issuing a total of 9,102,500 units (“Units”) of ImmunoPrecise at a price of $1.00 per Unit for gross proceeds of $9,102,500 (the “Financing”).
NameSilo Continues to Grow at one of the Fastest Rates in the Industry VANCOUVER, BRITISH COLUMBIA – (September 27, 2018) — Brisio Innovations Inc. (CSE: BZI) (PINKSHEETS: NTCEF) (the “Company”) is pleased to announce that its subsidiary, NameSilo, has surpassed the 2 million domain milestone. This puts NameSilo in the top 20 of the
Highlights Acquisition expands total attainable market for connected assets. Ascent’s durable “coaxial” Unmanned Aerial Vehicles (“UAV”) will allow mCloud to apply its complete AI- and IoT-powered cloud asset management solutions to remote and hard-to-access assets Acquisition is valued at an estimated $6.55M USD, comprised of $4.8M USD in shares and $500K USDof cash on closing, plus an additional $250K USD in